ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,267.84
-0.74%
Dow Jones
39,065.26
-1.53%
US Dollar vs MXN
16.74127
0.05%
Brent Oil
81.17
-0.17%
Bitcoin
67,884.20
-0.06%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Javelin Pharmaceuticals (JAV)

  7. Javelin Pharmaceuticals (JAV) Noticias

JAV

Javelin Pharmaceuticals (JAV)

Javelin Pharmaceuticals
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:JAV
FechaHoraFuenteTítuloSímboloCompañía
07/07/201005:00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)AMEX:JAVJavelin Pharmaceuticals
06/07/201012:14Edgar (US Regulatory)(25-NSE)AMEX:JAVJavelin Pharmaceuticals
02/07/201015:39Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)AMEX:JAVJavelin Pharmaceuticals
02/07/201015:24Edgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)AMEX:JAVJavelin Pharmaceuticals
02/07/201014:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:JAVJavelin Pharmaceuticals
02/07/201014:24Edgar (US Regulatory)Current report filing (8-K)AMEX:JAVJavelin Pharmaceuticals
01/07/201016:20Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)AMEX:JAVJavelin Pharmaceuticals
01/07/201013:59Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)AMEX:JAVJavelin Pharmaceuticals
01/07/201007:05Business WireJavelin Pharmaceuticals, Inc. Announces Successful Completion of Tender Offer for Its Common Stock by Hospira, Inc.AMEX:JAVJavelin Pharmaceuticals
30/06/201005:50GlobeNewswire Inc.Javelin Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.comAMEX:JAVJavelin Pharmaceuticals
21/06/201017:23Dow Jones News2nd UPDATE: Business Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
21/06/201015:08Dow Jones NewsUPDATE: Business Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
21/06/201009:33Dow Jones NewsBusiness Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
21/06/201007:30Business WireNews Release Service Inadvertently Issues Hoax Press Release Identifying Javelin Pharmaceuticals as IssuerAMEX:JAVJavelin Pharmaceuticals
11/06/201008:00Business WireJavelin Receives $2 Million Loan from HospiraAMEX:JAVJavelin Pharmaceuticals
07/06/201007:30Business WireJavelin Receives Notice from Hospira of Funding of LoanAMEX:JAVJavelin Pharmaceuticals
04/06/201015:05Business WireJavelin Receives Notice From NYSE Amex LLC of Non-ComplianceAMEX:JAVJavelin Pharmaceuticals
03/06/201006:30Business WireJavelin Commences Litigation against Hospira & Discus Acquisition Corporation, Asserts Hospira is in Breach of Merger Agreeme...AMEX:JAVJavelin Pharmaceuticals
26/05/201016:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:JAVJavelin Pharmaceuticals
24/05/201008:05Business WireJavelin Pharmaceuticals, Inc. Provides Update to Dyloject™ UK Supply ChainAMEX:JAVJavelin Pharmaceuticals
19/05/201007:59Business WireJavelin Pharmaceuticals, Inc. Comments on Tender Offer Extension by HospiraAMEX:JAVJavelin Pharmaceuticals
10/05/201015:16Business WireJavelin Pharmaceuticals, Inc. Reports First Quarter 2010 ResultsAMEX:JAVJavelin Pharmaceuticals
10/05/201014:01Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:JAVJavelin Pharmaceuticals
22/04/201005:02Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)AMEX:JAVJavelin Pharmaceuticals
21/04/201016:06Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)AMEX:JAVJavelin Pharmaceuticals
19/04/201016:20Business WireKendall Law Group Investigating Javelin Pharmaceuticals, Inc. Merger AgreementAMEX:JAVJavelin Pharmaceuticals
19/04/201015:44Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)AMEX:JAVJavelin Pharmaceuticals
19/04/201011:47Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)AMEX:JAVJavelin Pharmaceuticals
19/04/201008:49Dow Jones NewsJavelin, Myriad Officially Terminate Buyout DealAMEX:JAVJavelin Pharmaceuticals
19/04/201007:50Business WireJavelin Pharmaceuticals Announces Termination of Merger Agreement with Myriad Pharmaceuticals, Cancels Special Meeting of Sto...AMEX:JAVJavelin Pharmaceuticals
 Showing the most relevant articles for your search:AMEX:JAV

Su Consulta Reciente

BIT
WESG
Lyxor Msci World Esg Lea...
AMEX
SCE-D
Southern California Edison
BIT
S28730
Societe Generale Effekten
COIN
OOTETH
BIT
P22256
NLBNPIT22256 20240620 18...
NASDAQ
XTRBX
Federated Hermes Total R...
NASDAQ
FAQSX
Franklin Moderate Alloca...
BIT
UI241B
Unicredit Bank
TSXV
WMD
WeedMD
BIT
S27860
Societe Generale Effekten
BIT
P1CNA0
BNP Paribas Issuance
BIT
NSCIT874QEE9
EBRD
NASDAQ
EGRX
Eagle Pharmaceuticals
LSE
AS46
Bank Mont.23
BIT
S29279
Societe Generale Effekten
EU
XS2065698834
NIBC 0.01% until 15oct2029
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados